clindamycin has been researched along with Escherichia coli Infections in 35 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 19 (54.29) | 18.7374 |
1990's | 7 (20.00) | 18.2507 |
2000's | 4 (11.43) | 29.6817 |
2010's | 5 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hong, S; Krucker, T; Lee, LP; Lee, P; Moritz, TJ; Rath, CM; Tamrakar, P | 1 |
Kumar, A; Shahi, SK; Singh, VK | 1 |
Ami, MB; Keness, Y; Koshnir, A; Miron, D; Peleg, D; Peretz, A; Portnov, I; Rechnitzer, H; Reich, D; Salim, R; Shachar, IB; Wolf, MF | 1 |
Lee, JS; Pan, JY; Tan, M | 1 |
Giordano, S; Rintala, R; Taskinen, S | 1 |
Ketheesan, N; Norton, R; Porter, S | 1 |
Bartlett, PC; Erskine, RJ; Phipps, CR; VanLente, JL | 1 |
Luby, CD; Middleton, JR | 1 |
Actor, P; Grappel, SF; Phillips, L | 1 |
Justesen, T; Lykkegaard Nielsen, MC; Moesgaard, F | 2 |
Lamont, PM; Polk, HC; Trachtenberg, LS; West, CS | 1 |
Justesen, T; Lykkegaard Nielsen, MC; Moesgaard, F; Scheibel, JH | 1 |
Gorbach, SL | 1 |
Avlami, A; Daikos, GK; Giamarellou, H; Petrochilos, E; Tsatsiadis, K; Volanaki, M | 1 |
Collier, J; Goris, RJ; Saario, I; Van der Auwera, P; Willis, AT | 1 |
Adams, RB; May, AK; Pruett, TL; Rosenlof, LK; Sawyer, RG | 1 |
Galandiuk, S; Lamos, J; Montgomery, W; Polk, HC; Young, S | 1 |
Adams, RB; Pruett, TL; Sawyer, RG | 1 |
Brook, I | 1 |
Kim, HK; McGregor, CG; Miller, VM; Odell, J; Park, YS; Steckelberg, JM; Tazelaar, HD | 1 |
Cimbollek, M; Kreuter, J; Nies, B; Wenz, R | 1 |
Horii , T; Kimura, T; Kobayashi, M; Nadai, M | 1 |
Fass, RJ; Gardner, WG; Rotilie, CA; Ruiz, DE | 1 |
Fujimori, I; Koizumi, H; Shimada, S | 1 |
Ekwo, E; Peter, G | 1 |
Chuah, SK; Gollapudi, S; Hajji, M; Perumal, VK; Thadepalli, H | 1 |
Marradi, C; Nardone, A; Nespoli, A; Padalino, P | 1 |
Danziger, LH; Ferron, JL; Gauderer, MW; Gordon, N; Hau, T; Stellato, TA | 1 |
Hau, T; Hawkins, NL; Jacobs, DE | 1 |
Counts, GW; Coyle, MB; Dellinger, EP; Heimbach, DM; Lennard, ES; Minshew, BH; Schoenknecht, FD; Wertz, MJ | 1 |
Darrell, JH; Spiers, AS; Tattersall, MH | 1 |
Schoutens, E; Van Beers, D; Yourassowsky, E | 1 |
McHenry, MC; Turgeon, PL | 1 |
Fekety, FR; Kriewall, TJ; Ledger, WJ; Sweet, RL | 1 |
2 review(s) available for clindamycin and Escherichia coli Infections
Article | Year |
---|---|
Current experience with clindamycin in the treatment of abdominal and female pelvic infections.
Topics: Abdomen; Animals; Bacterial Infections; Bacteroides Infections; Clindamycin; Clinical Trials as Topic; Drug Therapy, Combination; Escherichia coli Infections; Female; Genital Diseases, Female; Humans; Male; Metronidazole; Prospective Studies; Rats; Rats, Inbred Strains | 1984 |
Moxalactam vs tobramycin-clindamycin. A randomized trial in secondary peritonitis.
Topics: Abscess; Adolescent; Adult; Bacteroides Infections; Clindamycin; Clinical Trials as Topic; Combined Modality Therapy; Drug Therapy, Combination; Escherichia coli Infections; Humans; Hypoprothrombinemias; Infant, Newborn; Middle Aged; Moxalactam; Peritonitis; Premedication; Prospective Studies; Random Allocation; Sepsis; Streptococcal Infections; Surgical Wound Infection; Tobramycin | 1988 |
6 trial(s) available for clindamycin and Escherichia coli Infections
Article | Year |
---|---|
Efficacy of systemic ceftiofur as a therapy for severe clinical mastitis in dairy cattle.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cephalosporins; Clindamycin; Escherichia coli; Escherichia coli Infections; Female; Injections, Intramuscular; Klebsiella; Klebsiella Infections; Mastitis, Bovine; Milk | 2002 |
Current experience with clindamycin in the treatment of abdominal and female pelvic infections.
Topics: Abdomen; Animals; Bacterial Infections; Bacteroides Infections; Clindamycin; Clinical Trials as Topic; Drug Therapy, Combination; Escherichia coli Infections; Female; Genital Diseases, Female; Humans; Male; Metronidazole; Prospective Studies; Rats; Rats, Inbred Strains | 1984 |
Ornidazole versus clindamycin: comparative evaluation in the treatment of 140 serious anaerobic infections.
Topics: Adolescent; Adult; Aged; Aminoglycosides; Anaerobiosis; Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Child; Clindamycin; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Nitroimidazoles; Ornidazole; Postoperative Complications; Prospective Studies; Random Allocation | 1982 |
A comparison of metronidazole and clindamycin for the treatment of intra-abdominal anaerobic infection: a multicentre trial.
Topics: Abdomen; Adolescent; Adult; Aged; Anaerobiosis; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Clindamycin; Escherichia coli Infections; Humans; Metronidazole; Middle Aged | 1982 |
Moxalactam vs tobramycin-clindamycin. A randomized trial in secondary peritonitis.
Topics: Abscess; Adolescent; Adult; Bacteroides Infections; Clindamycin; Clinical Trials as Topic; Combined Modality Therapy; Drug Therapy, Combination; Escherichia coli Infections; Humans; Hypoprothrombinemias; Infant, Newborn; Middle Aged; Moxalactam; Peritonitis; Premedication; Prospective Studies; Random Allocation; Sepsis; Streptococcal Infections; Surgical Wound Infection; Tobramycin | 1988 |
Stratified outcome comparison of clindamycin-gentamicin vs chloramphenicol-gentamicin for treatment of intra-abdominal sepsis.
Topics: Abdomen; Abscess; Adolescent; Adult; Aged; Bacteroides Infections; Chloramphenicol; Clindamycin; Clinical Trials as Topic; Drug Therapy, Combination; Escherichia coli Infections; Female; Gentamicins; Humans; Male; Middle Aged; Peritonitis; Prospective Studies; Random Allocation; Sepsis | 1985 |
29 other study(ies) available for clindamycin and Escherichia coli Infections
Article | Year |
---|---|
Assessing Antibiotic Permeability of Gram-Negative Bacteria via Nanofluidics.
Topics: Anti-Bacterial Agents; Clindamycin; Drug Discovery; Drug Resistance, Multiple, Bacterial; Equipment Design; Escherichia coli; Escherichia coli Infections; Gram-Negative Bacteria; Humans; Lab-On-A-Chip Devices; Nanotechnology; Permeability | 2017 |
Detection of Escherichia coli and associated β-lactamases genes from diabetic foot ulcers by multiplex PCR and molecular modeling and docking of SHV-1, TEM-1, and OXA-1 β-lactamases with clindamycin and piperacillin-tazobactam.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Clindamycin; Diabetic Foot; Escherichia coli; Escherichia coli Infections; Gene Expression; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Multiplex Polymerase Chain Reaction; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Structural Homology, Protein; Structure-Activity Relationship | 2013 |
Reconsidering the Current Preterm Premature Rupture of Membranes Antibiotic Prophylactic Protocol.
Topics: Amnion; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Chorioamnionitis; Clindamycin; Clinical Protocols; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Fetal Membranes, Premature Rupture; Gentamicins; Humans; Infant, Newborn; Infant, Newborn, Diseases; Klebsiella Infections; Microbial Sensitivity Tests; Placenta; Pregnancy; Retrospective Studies; Roxithromycin; Sepsis; Streptococcal Infections; Streptococcus agalactiae | 2015 |
A Case of Recalcitrant Actinomycosis Unresponsive to Antibiotic Therapy.
Topics: Actinomycosis; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalexin; Ciprofloxacin; Clindamycin; Coinfection; Drug Resistance, Bacterial; Escherichia coli Infections; Humans; Male; Pseudomonas Infections; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Thigh; Trimethoprim, Sulfamethoxazole Drug Combination | 2016 |
Xanthogranulomatous pyelonephritis infiltrating the liver.
Topics: Anti-Bacterial Agents; Cefuroxime; Cephalexin; Child; Clindamycin; Combined Modality Therapy; Diverticulum; Escherichia coli Infections; Hepatectomy; Humans; Kidney Calices; Kidney Diseases; Liver; Nephrectomy; Pyelonephritis, Xanthogranulomatous; Trimethoprim | 2008 |
Bacteraemias in tropical Australia: changing trends over a 10-year period.
Topics: Anti-Bacterial Agents; Australia; Bacteremia; Clindamycin; Cross Infection; Escherichia coli Infections; Gentamicins; Hospitals; Humans; Incidence; Microbial Sensitivity Tests; Retrospective Studies; Staphylococcal Infections; Time Factors; Tropical Climate; Urinary Tract Infections | 2013 |
Escherichia coli mastitis in cattle being treated for Staphylococcus aureus intramammary infection.
Topics: Animals; Anti-Bacterial Agents; Cattle; Clindamycin; Clonixin; Escherichia coli; Escherichia coli Infections; Female; Mastitis, Bovine; Milk; Prostaglandin Antagonists; Retrospective Studies; Risk Factors; Staphylococcal Infections | 2008 |
Activity of ceftizoxime and comparative compounds against Bacteroides fragilis in a mouse model of anaerobic infection.
Topics: Animals; Bacteroides fragilis; Bacteroides Infections; Cefotaxime; Cefoxitin; Ceftizoxime; Clindamycin; Cyclophosphamide; Escherichia coli Infections; Gentamicins; Mice | 1984 |
Experimental animal model of surgical wound infection applicable to antibiotic prophylaxis.
Topics: Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Clindamycin; Disease Models, Animal; Escherichia coli Infections; Gentamicins; Guinea Pigs; Premedication; Surgical Wound Infection | 1983 |
Non-specific host defence stimulation and antibiotic-resistant infection.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Animals; Anti-Bacterial Agents; Clindamycin; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Infections; Mice | 1983 |
Wound infection rates following preoperative versus intraoperative commencement of antibiotic prophylaxis.
Topics: Animals; Bacteroides fragilis; Bacteroides Infections; Clindamycin; Escherichia coli Infections; Gentamicins; Guinea Pigs; Intraoperative Period; Male; Premedication; Surgical Wound Infection | 1984 |
Wound infection rates after intraincisional plus systemic antibiotic prophylaxis in an animal model.
Topics: Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Clindamycin; Drug Therapy, Combination; Escherichia coli Infections; Gentamicins; Guinea Pigs; Premedication; Surgical Wound Infection | 1984 |
The role of Candida albicans in the pathogenesis of experimental fungal/bacterial peritonitis and abscess formation.
Topics: Abscess; Amphotericin B; Animals; Bacteroides fragilis; Bacteroides Infections; Candida albicans; Candidiasis; Cefotetan; Cefoxitin; Clindamycin; Colony Count, Microbial; Drug Combinations; Escherichia coli; Escherichia coli Infections; Male; Mice; Mice, Inbred BALB C; Peritoneal Diseases; Peritonitis; Survival Rate | 1995 |
Antibiotic penetration of experimental intra-abdominal abscesses.
Topics: Abdominal Abscess; Ampicillin; Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Cefmetazole; Cefoxitin; Ceftriaxone; Clindamycin; Drug Evaluation, Preclinical; Drug Therapy, Combination; Escherichia coli Infections; Hydrogen-Ion Concentration; Male; Mice; Microbial Sensitivity Tests; Spectinomycin; Sulbactam | 1995 |
Aztreonam vs. gentamicin in experimental peritonitis and intra-abdominal abscess formation.
Topics: Abdominal Abscess; Animals; Aztreonam; Bacteroides fragilis; Bacteroides Infections; beta-Lactam Resistance; Clindamycin; Colony Count, Microbial; Drug Combinations; Escherichia coli; Escherichia coli Infections; Gentamicins; Hydrogen-Ion Concentration; Hypoxia; Male; Mice; Mice, Inbred BALB C; Penicillin Resistance; Peritonitis | 1994 |
In vivo efficacies of quinolones and clindamycin for treatment of infections with Bacteroides fragilis and/or Escherichia coli in mice: correlation with in vitro susceptibilities.
Topics: 4-Quinolones; Abscess; Animals; Anti-Infective Agents; Bacteroides fragilis; Bacteroides Infections; Clindamycin; Colony Count, Microbial; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Mice; Microbial Sensitivity Tests | 1993 |
An animal model of pulmonary infection after single lung transplantation.
Topics: Analysis of Variance; Animals; Cefazolin; Clindamycin; Disease Models, Animal; Dogs; Drug Therapy, Combination; Escherichia coli Infections; Gentamicins; Graft Rejection; Immunosuppressive Agents; Lung Transplantation; Male; Neutrophils; Pneumonia, Bacterial; Postoperative Complications; Pulmonary Alveoli; Transplantation, Homologous | 1996 |
Antibiotic-impregnated heart valve sewing rings for treatment and prophylaxis of bacterial endocarditis.
Topics: Animals; Clindamycin; Endocarditis, Bacterial; Escherichia coli Infections; Gentamicins; Heart Valve Prosthesis; Humans; Mice; Microbial Sensitivity Tests; Rats; Staphylococcal Infections; Sutures | 1996 |
Lincomycin-induced endotoxin release in Escherichia coli sepsis: evidence for release in vitro and in vivo.
Topics: Animals; Anti-Bacterial Agents; Ceftazidime; Clindamycin; Endotoxins; Escherichia coli; Escherichia coli Infections; Humans; Lincomycin; Male; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Rats; Rats, Wistar; Sepsis | 2000 |
Clindamycin and gentamicin for aerobic and anaerobic sepsis.
Topics: Adolescent; Adult; Aged; Bacteroides Infections; Clindamycin; Escherichia coli Infections; Female; Fusobacterium Infections; Gentamicins; Humans; Infections; Klebsiella Infections; Male; Middle Aged; Pseudomonas Infections; Sepsis | 1977 |
[Clinical evaluation of clindamycin-2-phosphate in infectious diseases (author's transl)].
Topics: Acute Disease; Adult; Aged; Bronchitis; Cholecystitis; Chronic Disease; Clindamycin; Escherichia coli Infections; Female; Haemophilus Infections; Humans; Injections, Intramuscular; Injections, Intravenous; Male; Middle Aged; Mycoplasma Infections; Organophosphorus Compounds; Pneumonia; Pyelonephritis | 1977 |
Effect of clindamycin on aminoglycoside activity in a murine model of invasive Escherichia coli infection.
Topics: Aminoglycosides; Animals; Clindamycin; Escherichia coli Infections; Male; Mice; Mice, Inbred Strains; Neutropenia; Time Factors | 1976 |
Evaluation of temafloxacin in a rat model of intra-abdominal abscess.
Topics: Abdomen; Abscess; Animals; Anti-Infective Agents; Bacteroides fragilis; Bacteroides Infections; Clindamycin; Escherichia coli Infections; Feces; Fluoroquinolones; Gentamicins; Male; Quinolones; Rats; Rats, Inbred Strains | 1992 |
Cefotetan versus clindamycin/tobramycin association in mixed aero-anaerobic peritonitis in rats.
Topics: Acute-Phase Proteins; Animals; Bacteroides Infections; Cefotetan; Clindamycin; Drug Therapy, Combination; Escherichia coli Infections; Liver; Male; Muscles; Peritonitis; Proteins; Rats; Rats, Inbred Strains; Tobramycin | 1987 |
Antibiotics fail to prevent abscess formation secondary to bacteria trapped in fibrin clots.
Topics: Abscess; Ampicillin; Animals; Anti-Bacterial Agents; Ascites; Bacteroides fragilis; Bacteroides Infections; Blood Coagulation; Cefoxitin; Clindamycin; Escherichia coli; Escherichia coli Infections; Fibrin; Gentamicins; Male; Rats; Rats, Inbred Strains | 1986 |
Initial therapy with combination of five antibiotics in febrile patients with leukaemia and neutropenia.
Topics: Administration, Oral; Agranulocytosis; Anemia, Aplastic; Anti-Bacterial Agents; Bacterial Infections; Carbenicillin; Cephalothin; Clindamycin; Drug Combinations; Drug Hypersensitivity; Escherichia coli Infections; Fever; Gentamicins; Humans; Injections, Intravenous; Kanamycin; Klebsiella Infections; Leukemia; Leukocyte Count; Lymphoma; Methicillin; Penicillin G; Penicillin Resistance; Polymyxins; Probenecid; Pseudomonas Infections; Staphylococcal Infections | 1972 |
Clindamycin phosphate in severe infections mainly caused by Bacteroides fragilis: clinical and microbiological evaluation.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Bacteroides Infections; Carbenicillin; Cephalothin; Child; Clindamycin; Clostridium Infections; Clostridium perfringens; Drug Evaluation; Escherichia coli Infections; Female; Gentamicins; Humans; Infusions, Parenteral; Male; Microbial Sensitivity Tests; Middle Aged; Salmonella Infections; Sepsis; Staphylococcal Infections; Streptococcal Infections; Streptococcus pyogenes | 1974 |
Managing medical emergencies caused by bacterial infections.
Topics: Acute Disease; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacteroides Infections; Blood Volume; Child; Child, Preschool; Clindamycin; Cross Infection; Endocarditis, Bacterial; Enterocolitis, Pseudomembranous; Escherichia coli Infections; Gentamicins; Humans; Infant, Newborn; Infant, Newborn, Diseases; Meningitis; Meningococcal Infections; Pneumonia; Sepsis; Shock, Septic; Staphylococcal Infections | 1973 |
The use of parenteral clindamycin in the treatment of obstetric-gynecologic patients with severe infections. A comparison of a clindamycin-kanamycin combination with penicillin-kanamycin.
Topics: Adult; Anti-Bacterial Agents; Anticoagulants; Bacteria; Bacterial Infections; Bacteroides Infections; Clindamycin; Computers; Cross Infection; Drug Therapy, Combination; Escherichia coli Infections; Female; Fever; Genital Diseases, Female; Humans; Infusions, Parenteral; Injections, Intramuscular; Kanamycin; Penicillin G; Pregnancy; Pregnancy Complications, Infectious | 1974 |